Michael Skaff Reveals 19.9% Vivos Stake Following $1.6M Preferred Stock Investment
VVOS is trading near its 52-week low of $0.383 (9.7% above the low).
Summary
Michael Skaff's V-Co entities now hold 19.9% of Vivos Therapeutics after a $1.6M preferred stock and warrant purchase, injecting vital capital into a company confronting going concern and Nasdaq delisting risks.
Key Events · Ownership and Investor Activity · VVOS
-
Skaff Acquires 19.9% Stake
On June 30, 2026, Michael Skaff and his V-Co entities disclosed beneficial ownership of 2,783,102 shares, or 19.9%, following a $1.6M private placement of Series A Convertible Preferred Stock and warrants by V-Co 4.
-
Placement Priced at Premium
The preferred stock was acquired at $0.582 per share—a premium to the current $0.42 market price—with warrants exercisable at $0.456 per share. Of the $1.6M total, $1.1M was funded by converting an existing note.
-
Potential Control Exceeds 50%
Absent the 19.99% beneficial ownership blocker, Skaff's group could control an additional 18.4 million shares through warrants and preferred conversion, representing over 50% of the company.
-
Capital Infusion Amid Distress
The investment delivers critical funding as Vivos contends with a going concern warning, Nasdaq non-compliance for minimum equity, and a cash balance of just $1.2M as of Q1 2026.
Analysis · VVOS · Industrial Applications And Services
Through his V-Co entities, Michael Skaff has secured a 19.9% beneficial ownership in Vivos Therapeutics via a $1.6 million private placement of convertible preferred stock and warrants. Priced at $0.582 per share—a premium to the current $0.42 stock price—the deal includes a blocker capping ownership at 19.99%, yet without it, Skaff's group could command over 50% of the company. The investment arrives as Vivos grapples with a going concern warning, Nasdaq non-compliance, and a precarious cash position, making this both a critical lifeline and a significant concentration of influence in one investor's hands.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VVOS was trading at $0.42 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $0.38 to $7.03. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.